SENECA CO-PHARMA SLP
Company details
- Active NIF/CIF: B66555301
-
-
-
-
Address: Carrer de Llaceres, 15, 08173 Sant Cugat del Vallès, Barcelona, España See in map
-
-
Featured products:
More information on SENECA CO-PHARMA SLP
-
12/08/2020 | BORME act no.: 264796 | Register: BARCELONARevocaciones
-
12/08/2020 | BORME act no.: 264796 | Register: BARCELONANombramientos
-
10/05/2016 | BORME act no.: 200124 | Register: BARCELONATransformación de sociedad
-
10/05/2016 | BORME act no.: 200124 | Register: BARCELONAOtros conceptos
-
10/05/2016 | BORME act no.: 200124 | Register: BARCELONACambio de objeto social
-
03/08/2015 | BORME act no.: 320982 | Register: BARCELONAConstitución
-
03/08/2015 | BORME act no.: 320982 | Register: BARCELONANombramientos
Other information
The CIF assigned to SENECA CO-PHARMA SLP is B66555301, and its business status is active. The company is engaged in an economic activity classified within the CNAE 6201 - Actividades de programación informática. In addition, its SIC identification 7372 - Programación de ordenadores y software also defines it.
SENECA CO-PHARMA SLP employs a team of Between 1 and 9 employees and generates an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Barcelona, and has 4 executive positions. Its most recent announcement in the Borme was published on 12/08/2020, while its last deposit of ordinary annual accounts is for the 2018 fiscal year.
To access the contact information of SENECA CO-PHARMA SLP, such as the telephone number, postal address, or website, visit the Company Data module.
If you require more details about SENECA CO-PHARMA SLP, we invite you to consult one of our available financial reports, the company's Annual Accounts, or to check its payment incidents in the RAI delinquency file.
The financial, business, and legal information provided about SENECA CO-PHARMA SLP is extracted from official sources and is updated daily.
Do you want to know more about SENECA CO-PHARMA SLP??
Find out more about this company by consulting these reports: